Biotronik has released longer lengths—35mm and 40mm—of its Orsiro sirolimus-eluting stent, which has a biodegradable polymer matrix, to address a wider range of lesions. The new lengths mean that Biotronik now offers one of the longest drug-eluting stents on the market across all diameters.
The Orsiro 40 mm was first implanted by Heinz-Joachim Büttner of University Heart Center, Bad Krozingen, Germany. He said: “The low strut thickness and good deliverability of Orsiro is even more evident in long lengths. With the addition of the new sizes, there is now an Orsiro available for almost every case.”
The efficacy and safety of Orsiro was recently demonstrated in two studies, BIOFLOW-II and BIOFLOW-III.